All Stories

  1. A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma

    Article • International Journal of Pharmaceutics, June 2023, Elsevier

    Ana Francisco

  2. Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management

    Article • Biomedicine & Pharmacotherapy, January 2023, Elsevier

    Ana Francisco

  3. Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection

    Article • Pharmaceuticals, September 2022, MDPI AG

    Ana Francisco

  4. Fighting S. aureus catheter-related infections with sophorolipids: Electing an antiadhesive strategy or a release one?

    Article • Colloids and Surfaces B Biointerfaces, December 2021, Elsevier

    Ana Francisco

  5. Sulfur Analogues of Tyrosine in the Development of Triazene Hybrid Compounds: A New Strategy against Melanoma

    Article • ACS Medicinal Chemistry Letters, September 2021, American Chemical Society (ACS)

    Ana Francisco

  6. A single-step multicomponent synthesis of a quinoline derivative and the characterization of its cyclodextrin inclusion complex

    Article • Journal of Molecular Structure, August 2021, Elsevier

    Ana Francisco

  7. Preparation and characterization of a synthetic curcumin analog inclusion complex and preliminary evaluation of in vitro antileishmanial activity

    Article • International Journal of Pharmaceutics, November 2020, Elsevier

    Ana Francisco

  8. Pyromellitic dianhydride crosslinked soluble cyclodextrin polymers: Synthesis, lopinavir release from sub-micron sized particles and anti-HIV-1 activity

    Article • International Journal of Pharmaceutics, June 2020, Elsevier

    Ana Francisco

  9. Anticancer Triazenes: from Bioprecursors to Hybrid Molecules

    Article • Current Pharmaceutical Design, August 2019, Bentham Science Publishers

    Ana Francisco

  10. Cytotoxic Stilbenes and Derivatives as Promising Antimitotic Leads for Cancer Therapy

    Article • Current Pharmaceutical Design, February 2019, Bentham Science Publishers

    Ana Francisco, Vera Isca

  11. Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules

    Article • Current Medicinal Chemistry, January 2018, Bentham Science Publishers

    Ana Francisco

  12. The selective cytotoxicity of new triazene compounds to human melanoma cells

    Article • Bioorganic & Medicinal Chemistry, August 2017, Elsevier

    Ana Francisco

  13. Nanoformulations of a Triazene Analogue with Specific Affinity to Human Melanoma

    Article • Journal of Nanoscience with Advanced Technology, March 2016, Verizona Publisher Limited

    Ana Francisco

  14. Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives

    Article • PLoS ONE, May 2015, PLOS

    Rui Moreira, Ana Francisco

  15. Design and discovery of mushroom tyrosinase inhibitors and their therapeutic applications

    Article • Expert Opinion on Drug Discovery, April 2014, Informa Healthcare

    Ana Francisco

  16. Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines

    Article • European Journal of Medicinal Chemistry, December 2013, Elsevier

    Ana Francisco, Rafael Nunes, Paula Videira

  17. 18th Meeting of the European Society for Pigment Cell Research Lisbon, Portugal | 9-12 September 2013

    Article • Pigment Cell & Melanoma Research, August 2013, Wiley

    Ana Francisco

  18. Targets, Structures, and Recent Approaches in Malignant Melanoma Chemotherapy

    Article • ChemMedChem, August 2013, Wiley

    Ana Francisco

  19. The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics

    Article • Current Topics in Medicinal Chemistry, July 2013, Bentham Science Publishers

    Ana Francisco

  20. In vitro Antimicrobial Activity of Royleanone Derivatives Against Gram-Positive Bacterial Pathogens

    Article • Phytotherapy Research, March 2013, Wiley

    Professor Patrícia M Rijo, Ana Francisco

  21. Development of triazene prodrugs for ADEPT strategy: New insights into drug delivery system based on carboxypeptidase G2 activation

    Article • Bioorganic & Medicinal Chemistry Letters, November 2012, Elsevier

    Ana Francisco

  22. Antimycobacterial Metabolites fromPlectranthus:Royleanone Derivatives againstMycobacterium tuberculosisStrains

    Article • Chemistry & Biodiversity, April 2010, Wiley

    Professor Patrícia M Rijo, Ana Francisco

  23. Dopamine- and tyramine-based derivatives of triazenes: Activation by tyrosinase and implications for prodrug design

    Article • European Journal of Medicinal Chemistry, August 2009, Elsevier

    Rui Moreira, Ana Francisco

  24. Anticancer Therapeutics

    Article • November 2008, Wiley

    Dr Sotiris K Hadjikakou, Ana Francisco

  25. The Mechanism of Hydrolysis of Aryl Ether Derivatives of3-Hydroxymethyltriazenes

    Article • European Journal of Organic Chemistry, May 2005, Wiley

    Ana Francisco

  26. Triazene drug metabolites. Part 17: synthesis and plasma hydrolysis of acyloxymethyl carbamate derivatives of antitumour triazenes

    Article • Bioorganic & Medicinal Chemistry, July 2000, Elsevier

    Ana Francisco

  27. Liposomal formulation of netilmicin

    Article • International Journal of Pharmaceutics, February 1997, Elsevier

    Ana Francisco

  28. Liposomal formulations of Cu,Zn-superoxide dismutase: physico-chemical characterization and activity assessment in an inflammation model

    Article • Journal of Controlled Release, January 1997, Elsevier

    Ana Francisco

  29. Triazene drug metabolites. Part 14. Kinetics and mechanism of the acid-catalysed hydrolysis of 3-alkoxymethyl-3-alkyl-1-aryltriazenes

    Article • Journal of the Chemical Society Perkin Transactions 2, January 1994, Royal Society of Chemistry

    Ana Francisco

  30. Alkylating Agents

    Article • Wiley

    Rui Moreira, Ana Francisco